Cannabis Law Report
APRIL 8, 2022
as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS. Rick Doblin, Ph.D.,
TheAnswerPage
OCTOBER 27, 2021
Faculty of Medicine, The Hebrew University of Jerusalem, Member, Israel Academy of Science. whose book on medicinal plants was the leading text in pharmacology for many centuries, writes that it causes madness. Ethnopharmacology, 101, 16-26 (2005). Blog post by Professor Raphael Mechoulam. In the Jewish Talmud (300-600 C.E.)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
JANUARY 23, 2019
International Association for Cannabis as Medicine. International Association for Cannabis as Medicine. International Association for Cannabis as Medicine. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full – 2005). abst – 2005).
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Greencamp
FEBRUARY 2, 2019
Cannabis as medicine against HIV. But I haven’t seen any clinical trials looking at the direct effects of THC on the virus. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
Expert insights. Personalized for you.
52 
Let's personalize your content